Authors:
Gurgey, A
Haznedaroglu, IC
Egesel, T
Buyukasik, Y
Ozcebe, OI
Sayinalp, N
Dundar, SV
Bayraktar, Y
Citation: A. Gurgey et al., Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis, AM J HEMAT, 67(2), 2001, pp. 107-111
Citation: Ic. Haznedaroglu et al., A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway, MED HYPOTH, 54(1), 2000, pp. 80-83
Authors:
Egesel, T
Buyukasik, Y
Dundar, SV
Gurgey, A
Kirazli, S
Bayraktar, Y
Citation: T. Egesel et al., The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis, J CLIN GAST, 30(1), 2000, pp. 66-71
Authors:
Aytemir, K
Aksoyek, S
Buyukasik, Y
Haznedaroglu, I
Atalar, E
Ozer, N
Ovunc, K
Ozmen, F
Oto, A
Citation: K. Aytemir et al., Assessment of autonomic nervous system functions in patients with vitamin B-12 deficiency by power spectral analysis of heart rate variability, PACE, 23(6), 2000, pp. 975-978
Authors:
Ustundag, Y
Can, U
Benli, S
Buyukasik, Y
Ozbek, N
Citation: Y. Ustundag et al., Internal carotid artery occlusion in a patient with malignant peritoneal mesothelioma: Is it a sign of malignancy-related thrombosis?, AM J MED SC, 319(4), 2000, pp. 265-267
Authors:
Buyukasik, Y
Ileri, M
Ozcebe, OI
Haznedaroglu, IC
Yetkin, E
Kirazli, S
Korkmaz, S
Dundar, SV
Citation: Y. Buyukasik et al., Increased systemic coagulation activity in patients with rheumatic mitral stenosis: assessment of the clinical and echocardiographic determinants, BL COAG FIB, 10(7), 1999, pp. 417-421
Authors:
Ileri, NS
Buyukasik, Y
Karaahmetoglu, S
Ozatli, D
Sayinalp, N
Ozcebe, OI
Kirazli, S
Muftuoglu, O
Dundar, SV
Citation: Ns. Ileri et al., Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus, HAEMOSTASIS, 29(6), 1999, pp. 318-325
Authors:
Kosar, A
Haznedaroglu, S
Karaaslan, Y
Buyukasik, Y
Haznedaroglu, IC
Ozath, D
Sayinalp, N
Ozcebe, O
Kirazli, S
Dundar, S
Citation: A. Kosar et al., Effects of interferon-alpha 2a treatment on serum levels of tumor necrosisfactor-alpha, tumor necrosis factor-alpha 2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behcet's disease, RHEUM INTL, 19(1-2), 1999, pp. 11-14
Authors:
Ileri, M
Tandogan, I
Kosar, F
Yetkin, E
Buyukasik, Y
Kutuk, E
Citation: M. Ileri et al., Influence of thrombolytic therapy on the incidence of left ventricular thrombi after acute anterior myocardial infarction: Role of successful reperfusion, CLIN CARD, 22(7), 1999, pp. 477-480
Authors:
Ozatli, D
Kocoglu, H
Haznedaroglu, IC
Kosar, A
Buyukasik, Y
Ozcebe, O
Kirazli, S
Dundar, SV
Citation: D. Ozatli et al., Circulating thrombomodulin, thrombospondin, and fibronectin in acute myeloblastic leukemias, HAEMATOLOGI, 29(4), 1999, pp. 277-283
Citation: D. Ozatli et al., Could serum haptoglobin concentration be used as a marker of hypersplenismin chronic liver disease? (vol 93, pg 2641, 1998), AM J GASTRO, 94(3), 1999, pp. 866-866
Authors:
Haznedaroglu, IC
Buyukasik, Y
Kosar, A
Ozcebe, OI
Kirazli, S
Dundar, S
Citation: Ic. Haznedaroglu et al., Selectins and IL-6 during the clinical course of idiopathic thrombocytopenic purpura, ACT HAEMAT, 101(1), 1999, pp. 16-20
Authors:
Kosar, A
Haznedaroglu, IC
Buyukasik, Y
Ozcebe, O
Kirazli, S
Dundar, S
Citation: A. Kosar et al., Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmuneversus aplastic thrombocytopenia, HAEMATOLOG, 83(11), 1998, pp. 1055-1056
Authors:
Demiroglu, H
Yalcin, S
Buyukasik, Y
Ozcebe, OI
Dundar, S
Citation: H. Demiroglu et al., Increased erythrocyte aggregation as an indicator for an aggressive clinical course in Behcet's disease: a prospective study, ANN RHEUM D, 57(11), 1998, pp. 694-696
Authors:
Ozatli, D
Buyukasik, Y
Haznedaroglu, IC
Koc, H
Kosar, A
Simsek, H
Citation: D. Ozatli et al., Could serum haptoglobin concentration be used as a marker of hypersplenismin chronic liver disease?, AM J GASTRO, 93(12), 1998, pp. 2641-2642